• LAST PRICE
    302.1950
  • TODAY'S CHANGE (%)
    Trending Up3.3450 (1.1193%)
  • Bid / Lots
    302.1100/ 2
  • Ask / Lots
    302.2300/ 1
  • Open / Previous Close
    300.6000 / 298.8500
  • Day Range
    Low 299.3500
    High 304.9200
  • 52 Week Range
    Low 195.5000
    High 314.0000
  • Volume
    1,565,695
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 298.85
TimeVolumeLLY
09:32 ET67381301.5299
09:34 ET13058300
09:36 ET16786301.09
09:38 ET16415300.61
09:39 ET14304302.023
09:41 ET17604301.3193
09:43 ET10904301.6706
09:45 ET17341303.175
09:48 ET20378302
09:50 ET7559302.53
09:52 ET19630302.99
09:54 ET12049304.49
09:56 ET13613304
09:57 ET10826304.8
09:59 ET17808304.53
10:01 ET11763303.94
10:03 ET13282302.7658
10:06 ET10099303.38
10:08 ET3130303.29
10:10 ET5771302.465
10:12 ET5656302.841
10:14 ET13891303.12
10:15 ET5417303.565
10:17 ET6990302.91
10:19 ET6492303.17
10:21 ET6924303.52
10:24 ET1972303.65
10:26 ET3584303.1301
10:28 ET6013302.81
10:30 ET6408303.43
10:32 ET3892303.74
10:33 ET4038303.39
10:35 ET6569303.58
10:37 ET4353303.41
10:39 ET6714303.87
10:42 ET10435303.66
10:44 ET1183303.65
10:46 ET7509304.255
10:48 ET7099304.467
10:50 ET2836304.35
10:51 ET19283304.23
10:53 ET10590304.675
10:55 ET12974303.715
10:57 ET9159303.55
11:00 ET13556303.53
11:02 ET2985303.365
11:04 ET3309303.6
11:06 ET7504303.74
11:08 ET3402303.27
11:09 ET4452303.52
11:11 ET23624303.12
11:13 ET7363302.95
11:15 ET4026303.47
11:18 ET1821303.225
11:20 ET4441303.06
11:22 ET8213303.44
11:24 ET4895303.64
11:26 ET7763303.66
11:27 ET3678303.53
11:29 ET5052303.54
11:31 ET8040303.575
11:33 ET6410303.49
11:36 ET5659303.66
11:38 ET13227303.6344
11:40 ET4089303.71
11:42 ET6429303.5
11:44 ET6045303.295
11:45 ET6321302.885
11:47 ET10793302.35
11:49 ET12555302.16
11:51 ET10096302.315
11:54 ET6025302.34
11:56 ET4916302.42
11:58 ET6026302.38
12:00 ET12361302.12
12:02 ET2467302.47
12:03 ET4180302.78
12:05 ET1340302.76
12:07 ET4869302.55
12:09 ET5538302.74
12:12 ET2017303.03
12:14 ET3855303.32
12:16 ET2550303.06
12:18 ET2543302.945
12:20 ET2978302.53
12:21 ET12349302.79
12:23 ET600302.765
12:25 ET5258302.6192
12:27 ET9369302.405
12:30 ET4378302
12:32 ET2776301.995
12:34 ET5960302.69
12:36 ET4170302.225
12:38 ET3707302.315
12:39 ET3641302.74
12:41 ET3039302.2
12:43 ET5761301.84
12:45 ET5037301.54
12:48 ET651301.79
12:50 ET1653301.86
12:52 ET3992301.57
12:54 ET4970301.75
12:56 ET1233301.83
12:57 ET4270301.54
12:59 ET5543301.67
01:01 ET9830302.02
01:03 ET5197302.195
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLLY
Eli Lilly and Co
284.0B
44.8x
+18.88%
United StatesAZN
AstraZeneca PLC
202.6B
-201.4x
-50.95%
United StatesMRK
Merck & Co Inc
236.6B
17.2x
+28.17%
United StatesABBV
Abbvie Inc
266.9B
21.5x
+12.19%
United StatesAMGN
Amgen Inc
132.2B
24.6x
+0.08%
United StatesRHHBY
Roche Holding AG
270.3B
20.2x
+7.78%
As of 2022-05-23

Company Information

Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.

Contact Information

Headquarters
Lilly Corporate Ctr Drop Code 1094, Lilly Corporate CtrINDIANAPOLIS, IN, United States 46285-0001
Phone
317-276-2000
Fax
317-276-3492

Executives

President, Chief Executive Officer, Director
David Ricks
Chief Financial Officer, Senior Vice President
Anat Ashkenazi
Senior Vice President, Chief Information and Digital Officer
Diogo Rau
Senior Vice President, Chief Scientific and Medical Officer, President - Lilly Research Laboratories
Daniel Skovronsky
Senior Vice President - Enterprise Risk Management, Chief Ethics and Compliance Officer
Alonzo Weems

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$284.0B
Revenue (TTM)
$29.3B
Shares Outstanding
950.2M
Dividend Yield
1.30%
Annual Dividend Rate
3.9200 USD
Ex-Dividend Date
05-13-22
Pay Date
06-10-22
Beta
0.39
EPS
$6.74
Book Value
$9.42
P/E Ratio
44.8x
Price/Sales (TTM)
9.7
Price/Cash Flow (TTM)
36.6x
Operating Margin
24.56%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.